혈전성 미세혈관병증의 병리
Pathology of Thrombotic Microangiopathy
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
사구체에 면역글로불린은 음성이면서 C3 만 침착되는 경우, 다른 원인이 없는 경우 C3GN을 의심하여야 한다. 광학현미경으로는 세포의 증식이 있는 경우와 없는 경우가 있지만, 전자현미경으로는 EDD가 내피세포 밑으로 혹은 메산지움 등에 침착함을 확인하여야 한다. 대체보체경로의 조절이상이 원인임으로 혈청 C3 치를 비롯하여 CFH, CFI, CFB 등을 측정하여야 하며, C3 nephritic factor, antifactor H 자가항체 등을 조사하는 것이 필요하다. 보체 조절이상을 일으키는 유전자 돌연변이를 조사해 보아야 한다. 예후는 안정적이지만, 치료는 대증적이다. 이론적으로 보체의 활성화를 저지하는 약으로 가능할 것으로 생각되며, C5 항체인 eculizumab으로 치유된 보고도 있다.
Abstract
Thrombotic microangiopathy (TMA) is a microvascular thrombotic lesion caused by endothelial injury and subsequent formation of platelet rich thrombus. TMA is first described as a classical pathologic feature of HUS/TTP. Renal biopsy finding of TMA represents kidney involvement of HUS/TTP as well as other diseases such as malignant hypertension, drug toxicity, eclampsia, pre-eclampsia, and several systemic infections. Autoimmune diseases and transplant kidney sometime also have TMA. It is needed to consider a complete autoimmune work-up of patients presenting with TMA including tests for ANA, ANCA, and ADAMTS13 inhibitory antibodies, because there are several reports of association with TMA in patients of SLE, anti-phospholipid syndrome, and ANCA-associated vasculitis.
참고문헌 (40)
- Jenette JC, "Heptinstall's pathology of the kidney", pp.711~719 (2007), Lippincott Williams & Wilkins
- Symmers WSC, "Thrombotic microangiopathic hemolytic anemia(thrombotic microangiopathy)", Br Med J, 2, pp.897~903 (1952)
- Gasser C, "Hamolytisch-uamische syndrome:Bilaterale Nierenrinden-nekrosen bei akuten erworbenen hamolytischen Anamien", Schweia Med Wochenschr, 85, pp.905~909 (1955)
- Habib R, "Maladie thrombotique arteriolecapillaire du rein chez l'enf ant", Rev Fr Etud Clin Biol, 3, pp.891~894 (1958)
- Ruggenenti P, "Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura", Kidney Int, 60, pp.831~846 (2001)
- Benz K, "Thrombotic microangiopathy: new insights", Curr Opin Nephrol Hypertens, 19, pp.242~247 (2010)
- Brunskill SJ, "A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura", Transfus Med, 17, pp.17~35 (2007)
- Nachman PH, "Glomerular, vascular, and tubulointerstitial diseases", NephSAP, 7, pp.185~189 (2008)
- Nathanson S, "Acute neurological involvement in diar-rhea-associated hemolytic uremic syndrome", Clin J Am Soc Nephrol, 5, pp.1218~1228 (2010)
- Espinosa G, "Thrombotic microangiopathic hemolytic anemia and antiphospholipid antibodies", Ann Rheum Dis, 63, pp.730~736 (2004)
- Shibagaki Y, "Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)", thrombotic thrombocytopenic purpura(TTP): can we differentiate one from the other?, 2005, pp.28, 89~95
- McMinn JR, "Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy", J Clin Apheresis, 16, pp.202~209 (2001)
- Mannucci PM, "Changes in health and disease of the metalloproteinase that cleaves von Willebrand factor", Blood, 98, pp.2730~2735 (2001)
- Furlan M, "Aetology and pathogenesis of throm-botic thrombocytopenic purpura and hemolytic uremic syndrome. The role of von Willebrand factor-cleaving protease", Best Pract Res Clin Haematol, 14, pp.437~454 (2001)
- Dragon-Durey M-A, "Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: Report and genetic analysis of 16 cases", J Am Soc nephrol, 15, pp.787~795 (2004)
- Li PK, "Acute renal failure due to postpartum hemolytic uremic syndrome", Aus N Z J Obstet Gynecol, 28, pp.228~230 (1988)
- Kniaz D, "Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies: A case report and review of the literature", Am J Nephrol, 12, pp.126~133 (1992)
- Murgo AJ, "Cancer and chemotherapy-associated thrmobotic microangiopathy, in Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura", Marcel Dekker, Inc, 271 (1992)
- Remuzzi G, "Renal vascular and thrombotic effects of cyclosporine", Am J Kidney Dis, 13, pp.261~272 (1989)
- Eremia V, "VEGF inhibition and renal thrombotic microangiopathy", N Engl J Med, 358, pp.1129~1136 (2008)
- Gurevich F, "Renal effects of angiogenesis therapy: update for the internist", Am J Med, 122, pp.322~328 (2009)
- Zakarija A, "Ticlopidine and clopidogrel-associated thrombotic thrombocytopenic purpura(TTP); review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008)", Kidney Int Suppl, 112, pp.S20~S24 (2009)
- Gottschall JL, "Quinine induced immune thrombocytopeniaassociated with hemolytic uremic syndrome: A new clinical entity", Blood, 77, pp.306~310 (1991)
- Fine DM, "Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient", Semin Nephrol, 28, pp.545~555 (2008)
- Matsuyama T, "Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases", Thromb Haematol, 102, pp.371~378 (2009)
- Park YA, "Platelet count and prothrombin time help distinguish thrombotic thrmobocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults", Am J Clin Pathol, 133, pp.460~465 (2010)
- Satoskar AA, "De novo thrombotic microangiopapthy in renal allograft biopsies-role of antibody-mediated rejection", Am J Transplant, 10, pp.1804~1811 (2010)
- Ashman N, "Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombocytic microangiopathy", Am J transplant, 9, pp.424~427 (2009)
- Baid S, "Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients", J Am Soc Nepprol, 10, pp.146~153 (1999)
- Gallay BJ, "Glomerulonephritis in renal allografts associated with hepatitis C infection: a possible relationship with transplant glomerulopathy in two cases", Am J Kidney Dis, 26, pp.662~667 (1995)
- Cosio FG, "Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys", Am J Kidney Dis, 28, pp.752~758 (1996)
- Chansirikulchai S, "Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis", Clin J Am Soc Nephrol, 4, pp.345~353 (2009)
- Kwok SK, "Thrombotic thrombocytopenic purpura in systemic lupus erythema-tosus: risk factors and clinical outcome: a single center study", Lupus, 18, pp.16~21 (2009)
- Nesher G, "Thrombotic microangiopathic hemolytic anemia in systemic lupus erythematosus", Semin Arthritis Rheum, 24, pp.165~172 (1994)
- Hamasaki K, "Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review", Clin Rheumatol, 22, pp.355~358 (2003)
- Lansigan F, "Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13", Rheumatology, 50, pp.824~829 (2011)
- Watanabe H, "Thrombotic thrombocytopenic purpura in a patient with rapidly progressive glomerulonephritis with both anti-glomerular basement membrane antibodies and myeloperoxidase anti-neutrophil cytoplasmic antibodies", Clin Exp Nephrol, 14, pp.598~601 (2010)
- Asamiya Y, "Successful treatment with Rituximab in a patient with TTP secondary to severe ANCA-associated vasculitis", Inter Med, 49, pp.1589~1591 (2010)
- Agrawal V, "Concomitant thrombotic thrombocytopenic purpura and ANCA-associated vasculitis in an adolescent", Pediatr Nephrol, 26, pp.1317~1320 (2011)
- Noda S, "Thrombotic microangiopathy due to multiple autoantibodies related to antiphospholipid syndrome", Pediatr Nephrol, 27, pp.681~685 (2012)
